Application of Original Prostate Cancer Progression Model Interacting with Fibroblasts in Preclinical Research

Area of Science:

• Oncology
• Cell Biology
• Cancer Research

Background:

• Prostate cancer (PCa) is initially sensitive to androgen deprivation therapy (ADT).
• PCa often progresses to castration-resistant prostate cancer (CRPC) due to loss of androgen sensitivity and androgen receptor (AR) dependency.
• A model reflecting AR-positive cancer cells with reduced androgen sensitivity is needed to prevent CRPC.

Purpose of the Study:

• To establish a preclinical model of prostate cancer progression.
• To generate androgen-insensitive or weakly sensitive LNCaP sublines for studying CRPC development.
• To investigate the interaction of PCa models with fibroblasts for preclinical research.

Main Methods:

• Utilized limiting dilution of parental LNCaP cells to isolate sublines with varying androgen sensitivity.
• Established androgen-insensitive LNCaP sublines through continuous passage in hormone-depleted conditions.
• Developed an original PCa progression model incorporating fibroblast interactions.

Main Results:

• Successfully obtained several LNCaP sublines exhibiting diverse levels of androgen sensitivity and AR dependency.
• Established a distinct androgen-insensitive subline from parental LNCaP cells.
• Created a novel PCa progression model for preclinical applications.

Conclusions:

• The developed LNCaP sublines and PCa progression model offer a valuable tool for studying CRPC.
• This model can facilitate research into mechanisms driving resistance to ADT.
• The model holds potential for evaluating novel therapeutic strategies against advanced prostate cancer.